
Apollo Endosurgery APEN
Quarterly report 2022-Q3
added 05-16-2026
Apollo Endosurgery Operating Expenses 2011-2026 | APEN
Annual Operating Expenses Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 73.8 M | 54.2 M | 38 M | 49.2 M | 73.3 M | 62.2 M | 60.2 M | 64 M | 22.9 M | 15.6 M | 12.2 M | 13.1 M | 12.3 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 73.8 M | 12.2 M | 42.4 M |
Quarterly Operating Expenses Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 17 M | 17.5 M | 16.6 M | - | 13.7 M | 14.4 M | 11.3 M | - | 8.56 M | 6.73 M | 12.3 M | - | 12.3 M | 14.4 M | 9.79 M | - | 15.8 M | 16.7 M | 16.8 M | - | 14.8 M | 16 M | 16.3 M | - | 3.73 M | 2.67 M | 1.96 M | - | 2.29 M | 3.98 M | 3.81 M | - | 4.68 M | 5.66 M | 4.82 M | - | 4.33 M | 3.95 M | 2.59 M | - | 2.77 M | 2.41 M | 3.98 M | - | 2.48 M | 2.17 M | 2.68 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 17.5 M | 1.96 M | 8.67 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
47.1 M | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
301 M | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 13.52 | 0.6 % | $ 383 M | ||
|
Alphatec Holdings
ATEC
|
614 M | $ 8.29 | 0.12 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.18 | 5.36 % | $ 20 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
249 M | $ 1.75 | 13.64 % | $ 38.6 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.43 | 8.05 % | $ 26.8 M | ||
|
LivaNova PLC
LIVN
|
697 M | $ 79.7 | 0.39 % | $ 4.35 B | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 18.15 | 1.85 % | $ 426 M | ||
|
Pulmonx Corporation
LUNG
|
121 M | $ 1.28 | -6.57 % | $ 52.1 M | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 11.79 | 0.6 % | $ 422 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
LENSAR
LNSR
|
32.6 M | $ 5.72 | -1.72 % | $ 68.4 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Orthofix Medical
OFIX
|
344 M | $ 9.2 | -1.18 % | $ 364 M | ||
|
Electromed
ELMD
|
40.3 M | $ 37.44 | -0.5 % | $ 317 M | ||
|
MiMedx Group
MDXG
|
277 M | $ 3.68 | 2.22 % | $ 544 M | ||
|
Profound Medical Corp.
PROF
|
52.6 M | $ 6.71 | 1.28 % | $ 203 M | ||
|
Butterfly Network
BFLY
|
132 M | $ 5.63 | 1.62 % | $ 1.39 B | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
41.3 M | $ 1.35 | 16.38 % | $ 56.5 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
887 M | $ 77.32 | -3.82 % | $ 10.5 B | ||
|
Insulet Corporation
PODD
|
531 M | $ 148.14 | -1.04 % | $ 10.4 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 34.16 | -1.75 % | $ 1.06 B | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 41.13 | -3.68 % | $ 1.21 B | ||
|
Integer Holdings Corporation
ITGR
|
279 M | $ 90.85 | -0.14 % | $ 3.16 B | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 86.28 | 1.37 % | $ 50.5 B | ||
|
Sintx Technologies
SINT
|
11.2 M | $ 2.21 | 0.91 % | $ 6.13 M |